Publicacions en col·laboració amb investigadors/es de Hospital Universitario Son Espases (55)

2024

  1. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. The incidence of HIV-2 infection in Spain is declining – a registry data analysis

    International Journal of Infectious Diseases, Vol. 146

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  3. End of life in patients attended by pediatric palliative care teams: what factors influence the place of death and compliance with family preferences?

    European Journal of Pediatrics, Vol. 182, Núm. 5, pp. 2369-2377

  4. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34

2022

  1. Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups

    Cancers, Vol. 14, Núm. 22

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Occupational and Leisure Physical Activity on Cardiovascular Risk and Body Composition Among Courier Workers

    Biological Research for Nursing, Vol. 24, Núm. 4, pp. 560-572

2021

  1. Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

    European Journal of Haematology, Vol. 106, Núm. 6, pp. 842-850

  2. Gestión del proceso posanalítico en los laboratorios clínicos según los requisitos de la norma ISO 15189:2012. Consideraciones sobre la revisión, notificación y comunicación de los resultados

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 61-70

  3. Management of post-Analytical processes in the clinical laboratory according to ISO 15189:2012. Considerations about the management of clinical samples, ensuring quality of post-Analytical processes, and laboratory information management

    Advances in Laboratory Medicine, Vol. 2, Núm. 3, pp. 373-380

  4. Management of postanalytical processes in the clinical laboratory according to ISO 15189:2012 Standard requirements: Considerations on the review, reporting and release of results

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 51-59

  5. Resultados a 30 días en los pacientes mayores frágiles con insuficiencia cardiaca aguda dados de alta desde urgencias o sus unidades vinculadas que cumplen los criterios de alto riesgo del estudio DEED FRAIL-AHF

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 33, Núm. 3, pp. 165-173

2020

  1. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

    The Lancet Neurology, Vol. 19, Núm. 3, pp. 234-246

  2. Estimation of the risk of mortality after surgery in infective endocarditis: Comparison among specific risk scores

    Cirugia Cardiovascular, Vol. 27, Núm. 3, pp. 93-99

  3. Implementation of the recommendations for prevention of surgical site infection in Spain: A survey to evaluate the gap between evidence-based recommendations and daily clinical practice in cardiovascular surgery

    Cirugia Cardiovascular, Vol. 27, Núm. 1, pp. 16-21

  4. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer